<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02915328</url>
  </required_header>
  <id_info>
    <org_study_id>R323/15 - CCM334</org_study_id>
    <nct_id>NCT02915328</nct_id>
  </id_info>
  <brief_title>Role of the Type of Carotid Stent and Cerebral Protection on Cerebral Microembolization During Carotid Artery Stenting. A Randomized Study Comparing Carotid Wallstent vs Roadsaver® Stent and Distal vs Proximal Protection.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro Cardiologico Monzino</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro Cardiologico Monzino</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stenting is an alternative to traditional surgery in the treatment of carotid stenosis.The
      intra and/or postprocedural cerebral embolization remains the most frequent complication.

      The type of carotid stent and of cerebral protection are the two most important variables
      potentially affecting the rate of cerebral microembolization. So far there no consensus on
      the the best stent and cerebral protection.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of microembolization signals (MES) detected with transcranial doppler</measure>
    <time_frame>intraprocedural</time_frame>
    <description>different phases of carotid stenting (lesion wiring; predilation; stent crossing of the lesion; stent deployment; stent post dilation; device retrieval/deflation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical success</measure>
    <time_frame>day 2 or day 3 and day 30 complication</time_frame>
    <description>all strokes, major and minor strokes, myocardial infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 month clinical follow up</measure>
    <time_frame>6 month</time_frame>
    <description>all strokes, major and minor strokes, myocardial infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Doppler ultrasound assesment</measure>
    <time_frame>day 2 or day 3, 1 month and 6 month</time_frame>
    <description>stent patency and long term restenosis of target carotid artery and target vessel external carotid artery</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Carotid Stenosis</condition>
  <arm_group>
    <arm_group_label>Stent Roadsaver® +Filterwire EZ™</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The arm assess the efficacy of the combination of the stent Roadsaver® with the Filterwire EZ™ protection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stent Roadsaver® + MO.MA Ultra</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The arm assess the efficacy of the combination of the stent Roadsaver® with the MO.MA Ultra protection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Carotid Wallstent +MO.MA Ultra</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The arm assess the efficacy of the combination of the Carotid Wallstent with the MO.MA Ultra protection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Carotid Wallstent + Filterwire EZ™</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The arm assess the efficacy of the combination of the Carotid Wallstent with the Filterwire EZ™ protection</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Filterwire EZ™</intervention_name>
    <arm_group_label>Stent Roadsaver® +Filterwire EZ™</arm_group_label>
    <arm_group_label>Carotid Wallstent + Filterwire EZ™</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MO.MA Ultra</intervention_name>
    <arm_group_label>Stent Roadsaver® + MO.MA Ultra</arm_group_label>
    <arm_group_label>Carotid Wallstent +MO.MA Ultra</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stent Roadsaver®</intervention_name>
    <arm_group_label>Stent Roadsaver® +Filterwire EZ™</arm_group_label>
    <arm_group_label>Stent Roadsaver® + MO.MA Ultra</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Carotid Wallstent</intervention_name>
    <arm_group_label>Carotid Wallstent +MO.MA Ultra</arm_group_label>
    <arm_group_label>Carotid Wallstent + Filterwire EZ™</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        significant, unilateral carotid artery stenosis with soft plaque defined as:

          -  symptomatic patients: &gt; 1.3 m/sec peak systolic velocity and &gt; 50% diameter stenosis
             by Doppler ultrasound and &lt; 60 hounsfield unit by CT angiography

          -  asymptomatic patients &gt; 2.5 m/sec peak systolic velocity and &gt; 70% diameter stenosis
             by Doppler ultrasound and &lt; 60 hounsfield unit by CT angiography

        Exclusion Criteria:

          -  severe cerebral vasculopathy with cognitive impairment

          -  contraindication to double antiplatelet treatment

          -  controlateral carotid occlusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Piero Montorsi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centro Cardiologico Monzino, IRCCS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Piero Montorsi, MD</last_name>
    <phone>0039 0258002</phone>
    <phone_ext>576</phone_ext>
    <email>piero.montorsi@ccfm.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stefano Galli, MD</last_name>
    <phone>0039 02 58002</phone>
    <phone_ext>533</phone_ext>
    <email>stefano.galli@ccfm.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centro Cardiologico Monzino, IRCCS</name>
      <address>
        <city>Milan</city>
        <state>MI</state>
        <zip>20138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Piero Montorsi, MD</last_name>
      <phone>0038 0258002</phone>
      <phone_ext>576</phone_ext>
    </contact>
    <contact_backup>
      <last_name>Stefano Galli, MD</last_name>
      <phone>0038 0258002</phone>
      <phone_ext>533</phone_ext>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2016</study_first_submitted>
  <study_first_submitted_qc>September 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 27, 2016</study_first_posted>
  <last_update_submitted>September 23, 2016</last_update_submitted>
  <last_update_submitted_qc>September 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centro Cardiologico Monzino</investigator_affiliation>
    <investigator_full_name>Piero Montorsi</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

